Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lundbeck Reports Positive Phase III Study Results for Clobazam in the Adjunctive Treatment of Seizures Associated with Lennox-Gastaut Syndrome
Lundbeck Reports Positive Phase III Study Results for Clobazam in the Adjunctive Treatment of Seizures Associated with Lennox-Gastaut Syndrome
Lundbeck Reports Positive Phase III Study Results for Clobazam in the Adjunctive Treatment of Seizures Associated with Lennox-Gastaut Syndrome
Submitted by
admin
on December 5, 2010 - 12:11pm
Source:
BusinessWire
News Tags:
Lennox-Gastaut Syndrome
epilepsy
clobazam
Lundbeck
Headline:
Lundbeck Reports Positive Phase III Study Results for Clobazam in the Adjunctive Treatment of Seizures Associated with Lennox-Gastaut Syndrome
Do Not Allow Advertisers to Use My Personal information
